Medicare Enrolled
Dr. Syed Asad, M.D.
Nuclear Medicine · Jacksonville, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Asad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Asad?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Asad
Dr. Syed Asad is a nuclear medicine specialist in Jacksonville, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Asad performed 13,812 Medicare services across 1,401 unique beneficiaries.
Between the years covered by Open Payments, Dr. Asad received a total of $448,487 from 89 pharmaceutical and/or device companies across 2319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Asad is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 32% volume in FL
$448,487 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 93143 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗13,812
Medicare services
Top 32% in FL for nuclear medicine
1,401
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~727 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
11,800 | $5 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
633 | $87 | $473 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
408 | $121 | $543 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
222 | $81 | $1,523 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
189 | $62 | $404 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
126 | $115 | $602 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
115 | $181 | $3,488 |
| New patient office visit, complex (60-74 min) | 107 | $159 | $923 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
64 | $25 | $364 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
57 | $113 | $1,952 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
47 | $279 | $6,003 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
18 | $90 | $2,691 |
| Video EEG monitoring, 61-84 hours This procedure involves monitoring brain wave activity using an electroencephalogram (EEG) while simultaneously recording video for a duration of 61 to 84 hours. A healthcare professional reviews the data and provides a report. |
14 | $251 | $3,558 |
| Eye deviation and range of motion exam An examination to measure eye deviation and assess the range of motion of the eyes. |
12 | $48 | $1,376 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$448,487
Total received (2018-2024)
Avg $64,070/year across 7 years
Top 4% in FL for nuclear medicine
89
Companies
2,319
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$414,403 (92.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,522 (5.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,562 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,519
2023
$40,269
2022
$39,689
2021
$79,349
2020
$17,146
2019
$106,015
2018
$160,501
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Avanir Pharmaceuticals, Inc.
$298,750
Otsuka America Pharmaceutical, Inc.
$32,378
Supernus Pharmaceuticals, Inc.
$30,041
Biohaven Pharmaceuticals, Inc.
$24,576
AbbVie Inc.
$17,001
Novartis Pharmaceuticals Corporation
$7,405
Biohaven Pharmaceutical Holding Company Ltd.
$5,359
ABBVIE INC.
$4,782
Allergan, Inc.
$3,079
Amgen Inc.
$2,897
ARGENX US, INC.
$2,499
Teva Pharmaceuticals USA, Inc.
$1,579
EMD Serono, Inc.
$1,380
Abbott Laboratories
$1,260
Lilly USA, LLC
$950
Medtronic, Inc.
$944
Biogen, Inc.
$920
Alexion Pharmaceuticals, Inc.
$821
Lundbeck LLC
$772
Eisai Inc.
$659
JAZZ PHARMACEUTICALS INC.
$636
GENZYME CORPORATION
$626
Genentech USA, Inc.
$585
CSL Behring
$565
PFIZER INC.
$506
US WorldMeds, LLC
$506
Kyowa Kirin, Inc.
$475
Adamas Pharmaceuticals, Inc.
$402
UCB, Inc.
$352
Allergan Inc.
$346
Boston Scientific Corporation
$343
Medtronic USA, Inc.
$333
Promius Pharma LLC
$277
UPSHER-SMITH LABORATORIES LLC
$260
Neuronetics, Inc.
$254
ACADIA Pharmaceuticals Inc
$236
LivaNova USA, Inc.
$228
Neurelis, Inc.
$228
Neurocrine Biosciences, Inc.
$216
Corium, LLC
$154
EISAI INC.
$154
Celgene Corporation
$126
Janssen Pharmaceuticals, Inc
$123
E.R. Squibb & Sons, L.L.C.
$111
ASSERTIO THERAPEUTICS, Inc.
$110
Mallinckrodt Hospital Products Inc.
$102
Greenwich Biosciences, Inc.
$101
ARBOR PHARMACEUTICALS, INC.
$97
Acorda Therapeutics, Inc
$93
Takeda Pharmaceuticals U.S.A., Inc.
$93
Almatica Pharma LLC
$93
SK Life Science, Inc.
$90
TerSera Therapeutics LLC
$88
Upsher-Smith Laboratories LLC
$88
Grifols USA, LLC
$83
Bausch Health US, LLC
$79
Merz North America, Inc.
$76
Mallinckrodt LLC
$69
Sunovion Pharmaceuticals Inc.
$68
Mallinckrodt Enterprises LLC
$63
MDD US Operations, LLC
$62
Zyla Life Sciences, Inc.
$62
Zyla Life Sciences
$61
CATALYST PHARMACEUTICALS, INC.
$58
GE Healthcare
$56
MITSUBISHI TANABE PHARMA AMERICA, INC.
$53
Mitsubishi Tanabe Pharma America, Inc.
$47
Merz Pharmaceuticals, LLC
$47
Axsome Therapeutics, Inc.
$43
Flowonix Medical Incorporated
$43
Vanda Pharmaceuticals Inc.
$41
Currax Pharmaceuticals LLC
$39
TG Therapeutics, Inc.
$37
Arbor Pharmaceuticals, Inc.
$34
Merck Sharp & Dohme LLC
$34
BOSTON SCIENTIFIC CORPORATION
$31
Egalet US Inc
$30
Impax Laboratories, Inc.
$24
Amneal Pharmaceuticals LLC
$22
Averitas Pharma Inc.
$21
Validus Pharmaceuticals LLC
$21
Marinus Pharmaceuticals, Inc.
$21
Octapharma USA, Inc.
$19
MERZ NORTH AMERICA, INC.
$19
Azurity Pharmaceuticals, Inc.
$18
Vertical Pharmaceuticals, LLC
$17
Assertio Therapeutics, Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$12
Pernix Therapeutics Holdings, Inc.
$11
Top 3 companies account for 80.5% of total payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · BYSTOLIC · Betaseron · Briviact · CONTRAVE · COPAXONE · Cambia · Dayvigo · EMGALITY · EPIDIOLEX · Epidiolex · Equetro · FIRDAPSE · FORTEO · Fycompa · GENERAL DBS · GENERAL - DBS · GILENYA · GOCOVRI · GRALISE · Gamunex-C · General - DBS · Gocovri · Gralise · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEMTRADA · LINZESS · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONZETRA Xsail · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PERCEPT PC BRAINSENSE · PONVORY · PRIALT · Ponvory · Privigen · Proclaim DRG IPG · Proclaim IPG · Prometra II · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SILENOR · SOLIRIS · SPRAVATO · SPRIX · Soliris · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS - Sentiva · VNS Therapy · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · XEOMIN · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTALMY · Zembrace · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nuclear medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for nuclear medicine in FL.
Equivalent to $3,247 per 100 Medicare services performed
Geographic Context
Nuclear medicines within 10 mi
3
Per 100K population
0.3
County median income
$68,447
Nearest hospital
NH Jacksonville
4.0 mi
4.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Asad is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 4% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Asad experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Asad performed 11,800 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Asad receive payments from pharmaceutical companies?
Yes. Dr. Asad received a total of $448,487 from 89 companies across 2,319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Asad's costs compare to other nuclear medicines in Jacksonville?
Dr. Asad's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Asad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Nuclear Medicines in Jacksonville
Browse nuclear medicines in Jacksonville ranked by procedure volume and transparency data.
Highest volume
Top Nuclear Medicines in FL
Nuclear medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nuclear Medicines in FL
Which FL nuclear medicines receive the most from drug and device companies.
By company
Avanir Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Avanir Pharmaceuticals, Inc.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology